Key result
Hepatitis C virus infection was significantly more prevalent in patients with dilated cardiomyopathy compared to those with ischemic heart disease (16.7% vs 2.5%; P<.05).
Why the study?
Is hepatitis C virus infection associated with dilated cardiomyopathy compared to ischemic heart disease?
Case-Control (n=76)
Is hepatitis C virus infection associated with dilated cardiomyopathy compared to ischemic heart disease?
Absolute Event Rate: 16.7% vs 2.5%
p-value: p=<.05
Hepatitis C virus infection is significantly more prevalent in patients with dilated cardiomyopathy than in those with ischemic heart disease, suggesting a potential causal role in its pathogenesis.
No takes yet. Share an insight, caveat, or question.
HCV may be linked to dilated cardiomyopathy; leaves open causal role requiring prospective confirmation.
Matsumori et al. (1995) conducted a case-control in Dilated cardiomyopathy (n=76). Hepatitis C virus infection vs. Ischemic heart disease (control group) was evaluated on Presence of anti-hepatitis C virus antibody in sera (p=<.05). Hepatitis C virus infection was significantly more prevalent in patients with dilated cardiomyopathy compared to those with ischemic heart disease (16.7% vs 2.5%; P<.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: